Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Omalizumab for treating antihistamine-resistant chronic spontaneous urticaria
Drug guidance

Omalizumab for treating antihistamine-resistant chronic spontaneous urticaria

Skin

2 January 2019

Guidance Recommendations

Subsidy status

Back to top